EUCTR2005-005631-97-IT进行中（未招募）1 期
/A - CAPPA-2 (PS-2)
ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI - FONDAZIONE G. PASCALE0 个研究点目标入组 360 人开始时间: 2007年7月17日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 360
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
招募中
1 期
Phase 1 study in Staphylococcus aureus endocarditisInfectious S. aureus endocarditisMedDRA version: 20.1Level: LLTClassification code: 10041937Term: Staphylococcus aureus endocarditis Class: 10021881CTIS2023-505413-25-00Phaxiam Therapeutics12
进行中（未招募）
1 期
A Phase I, open-label, randomized, two period, cross-over study in healthy subjects to assess the bioavailability of different formulations of deucrictibant administered as single dose under fasting condition.Hereditary angioedema (HAE)MedDRA version: 23.1Level: PTClassification code: 10019860Term: Hereditary angioedema Class: 100000004850CTIS2024-511196-15-00Pharvaris Netherlands B.V.14
进行中（未招募）
1 期
A Phase 1/Phase 2 Trial to Evaluate Safety, Immunogenicity and PSA Response of VTP-850 Prostate Cancer Immunotherapeutic in Men with Biochemical Recurrence after Definitive Local Therapy for Prostate CancerProstate CancerCTIS2023-504066-39-00Vaccitech PLC117
进行中（未招募）
不适用
/AType 2 diabetes mellitusEUCTR2007-003393-25-CZsanofi-aventis, s.r.o.
招募中
1 期
A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination with Standard of Care and in Recurrent Glioblastoma as a Single Agent.MedDRA version: 20.0Level: PTClassification code: 10018336Term: Glioblastoma Class: 100000004864GlioblastomaCTIS2023-506719-17-00ovartis Pharma AG55